title: Delivered dose estimate to standardize airway hyperresponsiveness assessment in mice.
abstract: Airway hyperresponsiveness often constitutes a primary outcome in respiratory studies in mice. The procedure commonly employs aerosolized challenges, and results are typically reported in terms of bronchoconstrictor concentrations loaded into the nebulizer. Yet, because protocols frequently differ across studies, especially in terms of aerosol generation and delivery, direct study comparisons are difficult. We hypothesized that protocol variations could lead to differences in aerosol delivery efficiency and, consequently, in the dose delivered to the subject, as well as in the response. Thirteen nebulization patterns containing common protocol variations (nebulization time, duty cycle, particle size spectrum, air humidity, and/or ventilation profile) and using increasing concentrations of methacholine and broadband forced oscillations (flexiVent, SCIREQ, Montreal, Qc, Canada) were created, characterized, and studied in anesthetized naïve A/J mice. A delivered dose estimate calculated from nebulizer-, ventilator-, and subject-specific characteristics was introduced and used to account for protocol variations. Results showed that nebulization protocol variations significantly affected the fraction of aerosol reaching the subject site and the delivered dose, as well as methacholine reactivity and sensitivity in mice. From the protocol variants studied, addition of a slow deep ventilation profile during nebulization was identified as a key factor for optimization of the technique. The study also highlighted sensitivity differences within the lung, as well as the possibility that airway responses could be selectively enhanced by adequate control of nebulizer and ventilator settings. Reporting results in terms of delivered doses represents an important standardizing element for assessment of airway hyperresponsiveness in mice.
authors: SCIREQ Scientific Respiratory Equipment, Inc., Montreal, Quebec, Canada annette.robichaud@scireq.com.
authors: Annette
authors: A
authors: Robichaud
authors: SCIREQ Scientific Respiratory Equipment, Inc., Montreal, Quebec, Canada.
authors: Liah
authors: L
authors: Fereydoonzad
authors: SCIREQ Scientific Respiratory Equipment, Inc., Montreal, Quebec, Canada.
authors: Thomas F
authors: TF
authors: Schuessler
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D008297:Male; D016210:Methacholine Chloride / Q000633:toxicity*; D051379:Mice; D009330:Nebulizers and Vaporizers / Q000592:standards; D012015:Reference Standards; D012107:Research Design; D012130:Respiratory Hypersensitivity / Q000139:chemically induced*
chemical_list: D000336:Aerosols; D016210:Methacholine Chloride
keywords: airway hyperresponsiveness; delivered dose; forced oscillation technique; methacholine; nebulizer